ATP-Citrate Lyase as a Target for Hypolipidemic Intervention. 2. Synthesis and Evaluation of (3R*,5S*)-ω-Substituted-3-carboxy-3,5-dihydroxyalkanoic Acids and Their γ-Lactone Prodrugs as Inhibitors of the Enzyme in Vitro and in Vivo
Author:
Affiliation:
1. Departments of Medicinal Chemistry, Vascular Biology, Mechanistic Enzymology, and Analytical Sciences, SmithKline Beecham Pharmaceuticals Ltd, New Frontiers Science Park (North), Third Avenue, Harlow, Essex CM19 5AW, U.K.
Publisher
American Chemical Society (ACS)
Subject
Drug Discovery,Molecular Medicine
Link
https://pubs.acs.org/doi/pdf/10.1021/jm980091z
Reference33 articles.
1. Purification and some kinetic properties of rat liver ATP citrate lyase
2. Purification and Kinetic Studies of the Citrate Cleavage Enzyme
3. (d) Walsh, C.Enzyme ReactionMechanisms; W. H. Freeman and Co. San Francisco, 1979; pp 766−768.
4. ATP-Citrate Lyase as a Target for Hypolipidemic Intervention. Design and Synthesis of 2-Substituted Butanedioic Acids as Novel, Potent Inhibitors of the Enzyme
Cited by 23 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Recent advance of ATP citrate lyase inhibitors for the treatment of cancer and related diseases;Bioorganic Chemistry;2024-01
2. Opportunities and Challenges for Inhibitors Targeting Citrate Transport and Metabolism in Drug Discovery;Journal of Medicinal Chemistry;2023-07-10
3. Discovery of Novel Long‐Chain Alkenyl Diacid Derivatives as ACLY Inhibitors;Chinese Journal of Chemistry;2022-08-29
4. ATP-citrate lyase (ACLY) inhibitors as therapeutic agents: a patenting perspective;Expert Opinion on Therapeutic Patents;2022-04-25
5. The vital role of ATP citrate lyase in chronic diseases;Journal of Molecular Medicine;2019-12-19
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3